Neoleukin Therapeutics (NASDAQ:NLTX) Earnings Information
Neoleukin Therapeutics last released its earnings data on March 24th, 2021. The reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.21) by $0.03. Neoleukin Therapeutics has generated ($0.75) earnings per share over the last year. Neoleukin Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.
Neoleukin Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Neoleukin Therapeutics (NASDAQ:NLTX) Earnings Estimates
2021 EPS Consensus Estimate: ($1.25)
2022 EPS Consensus Estimate: ($1.70)
Neoleukin Therapeutics (NASDAQ NLTX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)